Blog

Most AI agents are evaluated on narrow tasks that don’t capture the complexity of real-world challenges like drug discovery. That’s why we created the DO Challenge — a new benchmark designed to test autonomous agentic systems in a resource-constrained, simulated drug discovery environment.

Our take on the biggest trends and best observations at JPM '25

We review a recent vision for an AI Virtual Cell, and contrast it to Deep Origin's approach

Three chemists go on a hike and discuss how AI factors into drug discovery today and in the near future.

In this post I will describe some of the primary challenges facing R&D teams in biotech companies, and how we at Deep Origin believe we can tackle these problems to make you more productive and successful.